Status:
UNKNOWN
The Effects of DPPIs on Cognitive Function of Diabetic Patients
Lead Sponsor:
Beni-Suef University
Collaborating Sponsors:
Clinical Pharmacy Department, Faculty of Pharmacy, 6 October University
Faculty of Medicine, Minia University
Conditions:
Cognitive Impairment
Eligibility:
All Genders
45-60 years
Phase:
PHASE4
Brief Summary
This is a single-center, randomized controlled clinical trial with a parallel-group design conducted at Minia University hospital.
Detailed Description
All patients admitted to Diabetes clinics of Minia University Hospital, will be screened for the eligibility criteria. diabetic patients (aged above 50 years) with uncontrolled diabetes on oral hypog...
Eligibility Criteria
Inclusion
- Type-2 diabetic adult subjects (above 50 years old) who had uncontrolled (A1c=8-9 %) blood glucose levels with an oral hypoglycemic drug at the screening visit were eligible to participate.
Exclusion
- Those with type1 diabetes or ketoacidosis, end organ failure as chronic renal failure (estimated serum creatinine level ≥ 1.5mg/dl in male and ≥ 1.4mg/dl in female), liver cell failure (elevated alanine transaminase (ALT) and aspartate transaminase (AST) ≥ 2 folds), and heart failure, previous history of pancreatitis, and pregnant or lactating females were excluded from the study.
Key Trial Info
Start Date :
December 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2024
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT06164535
Start Date
December 30 2023
End Date
July 15 2024
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia University hospital
Minya, Egypt, 82511